Details for Patent: 7,638,522

« Back to Dashboard

Summary for Patent: 7,638,522

Title:	Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino] benzonitrile
Abstract:	The present invention relates to a pharmaceutical composition comprising as active ingredient the hydrochloric acid salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethyl-phenyl]amino]-2-pyrimidinyl]amino]benzonitrile and to processes for their preparation.
Inventor(s):	Jérôme Emile Georges Guillemont, Paul Theodoor Agnes Stevens, Alex Herman Copmans, Jozef Peeters, Alfred Elisabeth Stappers, Roger Petrus Gerebern Vandecruys, Paul Stoffels
Assignee:	Janssen Pharmaceutica NV
Application Number:	US11/219,163
Patent Claim Types: see list of patent claims	Composition; Compound;

Drugs Protected by US Patent 7,638,522

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate

Foreign Priority and PCT Information for Patent: 7,638,522

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
	01203090	Aug 13, 2001
	02077748	Jun 10, 2002
	03103275	Sep 03, 2003
	03103319	Sep 08, 2003
	03103335	Sep 10, 2003

International Family Members for US Patent 7,638,522

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
European Patent Office	1419152		C300529	Netherlands
European Patent Office	1419152		C300532	Netherlands
European Patent Office	1419152		PA2012008	Lithuania
European Patent Office	1419152		PA2012009	Lithuania
European Patent Office	1419152		CA 2012 00021	Denmark